Curnel, A., Nicolas, E., Nijskens, C., Torres, D., Evrard, B., Piel, G., & Berger, M. (30 January 2026). Impact of lipid composition on gene delivery efficiency of siRNA lipid nanoparticle in breast cancer [Paper presentation]. CIRM Day. |
Degey, M., Berger, M., Stephan, R., Hego, A., Ormenese, S., Evrard, B., Piel, G., & Maquoi, E. (30 January 2026). A multiparametric kinetic in vitro assay for siRNA–LNP efficacy and toxicity: live-cell imaging cross-validated with flow cytometry [Paper presentation]. CIRM DAY. |
  | Curnel, A., Degey, M., Torres, D., Evrard, B., Nicolas, E., Piel, G., & Berger, M. (01 October 2025). Optimization of siRNA-based lipid nanoparticle formation to enhance gene delivery and improve efficacy in breast cancer treatment [Poster presentation]. 5th Conference on Innovation in Drug Delivery. |
Debuigne, A., Berger, M., Toussaint, F., Ben Djemaa, S., Jérôme, C., Lechanteur, A., Mottet, D., & Piel, G. (07 May 2025). Lipid-poly(N-vinylamide) conjugates as PEG alternatives towards safer and efficient siRNA delivery systems [Paper presentation]. Advanced Polymers via Macromolecular Engineering [APME], Catania, Italy.  Peer reviewed |
 | Berger, M., Degey, M., Curnel, A., Evrard, B., & Piel, G. (2025). The benefits of emerging alternatives to PEG for lipid nanoparticle RNA delivery systems. Nanomedicine, 1 - 3. doi:10.1080/17435889.2025.2500917 Peer Reviewed verified by ORBi |
Berger, M. (30 April 2025). Développement de nanoparticules lipidiques basées sur des alternatives au PEG pour l’administration efficace de siARN [Paper presentation]. Séance Académique de l'Académie nationale de Pharmacie, Paris, France. Peer reviewed |
Curnel, A., Degey, M., Evrard, B., Piel, G., & Berger, M. (31 March 2025). Production and characterization of lipid nanoparticle formulations with different ionizable lipids in order to compare their cell efficacy and toxicity [Paper presentation]. 22nd Forum of Pharmaceutical Sciences, La Roche-en-Ardenne, Belgium. Editorial reviewed |
Degey, M., Berger, M., Debuigne, A., Jérôme, C., Evrard, B., Maquoi, E., Leblond Chain Jeanne, & Piel, G. (29 January 2025). ADVANCING siRNA DELIVERY: DSPE-PNMVA AS A SOLUTION TO THE PEG DILEMMA IN LNP [Paper presentation]. CIRM DAY, Liège, Belgium. |
 | Degey, M., Berger, M., Meloni, L., Pedergnana, S., Debuigne, A., Jérôme, C., Evrard, B., Maquoi, E., Leblond Chain Jeanne, & Piel, G. (2025). Redesigning lipid nanoparticles for enhanced intravenous delivery for cancer treatment: PNMVA as a promising PEG substitute [Poster presentation]. 5th Conference on Innovation in Drug Delivery, Turin, Italy. |
 | Degey, M., Berger, M., Meloni, L., Pedergnana, S., Debuigne, A., Jérôme, C., Evrard, B., Maquoi, E., Leblond Chain Jeanne, & Piel, G. (2025). Redefining PEGylation: PNMVA-driven innovation in lipid nanoparticle delivery for cancer therapy [Poster presentation]. ESCGT, Séville, Spain. |
 | Degey, M., Berger, M., Meloni, L., Pedergnana, S., Debuigne, A., Jérôme, C., Evrard, B., Maquoi, E., Leblond Chain Jeanne, & Piel, G. (2025). Beyond PEGylation: PNMVA as a novel driver of lipid nanoparticle advances in cancer therapy [Poster presentation]. Biomaterial Day. |
Degey, M., Meloni, L., Penoy, N., Sacre, P.-Y., Berger, M., Dede, B., Guerreiro Inês, Evrard, B., Leblond Chain Jeanne, Piel, G., & Maquoi, E. (2025). Optimizing siRNA-loaded lipid nanoparticle lyophilization through QbD approach with stability characterization [Poster presentation]. Biomaterial Day. |
 | Degey, M., Berger, M., Debuigne, A., Jérôme, C., Evrard, B., Leblond Chain Jeanne, & Piel, G. (03 December 2024). ADVANCING siRNA DELIVERY: DSPE-PNMVA24 AS A SOLUTION TO THE PEG DILEMMA IN LNP FOR TUMOR TARGETING [Poster presentation]. SF Nano. |
Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Leblond Chain, J., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (December 2024). Development of lipid nanoparticles based on PEG alternatives for efficient siRNA delivery [Paper presentation]. 1Oth annual meeting of SFNano, Toulouse, France. Peer reviewed |
Debuigne, A., Piel, G., Mottet, D., Toussaint, F., Berger, M., Ben Djemaa, S., & Lechanteur, A. (07 November 2024). Polymer derivatives and their use as lipid nanoparticle modifiers. |
Debuigne, A., Piel, G., Mottet, D., Toussaint, F., Berger, M., Ben Djemaa, S., & Lechanteur, A. (06 November 2024). Polymer derivatives and their use as lipid nanoparticle modifiers. |
 | Degey, M., Berger, M., Debuigne, A., Jérôme, C., Evrard, B., Leblond Chain, J., & Piel, G. (28 October 2024). Impact of lipid-polymer type and content on Lipid Nanoparticles (LNPs) physico-chemical properties and protein corona formation [Poster presentation]. CRS BNLF Local Chapter, Gand, Belgium. |
Debuigne, A., Berger, M., Toussaint, F., Ben Djemaa, S., Jérôme, C., Lechanteur, A., Mottet, D., & Piel, G. (24 April 2024). Poly(N-vinyl amide)-lipid conjugates as poly(ethylene glycol) alternatives for the modification of lipid-based nanocarriers [Paper presentation]. Materials Research Society (MRS) Spring Meeting, Seattle, United States. Peer reviewed |
 | Degey, M., Berger, M., Evrard, B., & Piel, G. (10 April 2024). Exploring alternatives to PEG for the formulation of lipid nanoparticles encapsulating siRNA [Poster presentation]. 17th European Symposium on Controlled Drug Delivery. |
Berger, M., Toussaint, F., Ben Djemaa, S., Maquoi, E., Pendeville-Samain, H., Evrard, B., Jérôme, C., Leblond Chain, J., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (March 2024). Innovative siRNA-based lipid nanoparticles decorated with PEG alternatives (PNVP and PNMVA) to circumvent dilemma and immunogenicity [Paper presentation]. 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical (PBP) Technology, Vienne, Austria. Peer reviewed |
 | Degey, M., Berger, M., Evrard, B., & Piel, G. (31 January 2024). New amphiphilic polymers with variable length and number of lipid chains as alternatives to PEG for the formulation of lipid nanoparticles encapsulating siRNA [Poster presentation]. CIRM DAY - Scientific day, Liege, Belgium. |
Penoy, N., Delma, K. L., Berger, M., Evrard, B., & Piel, G. (2024). Supercritical fluid methods for liposome production and sterilization. In Antimisiaris Sophia G., Liposomes in drug delivery : what, where, how and when to deliver. Elsevier. doi:10.1016/B978-0-443-15491-1.00003-1 Peer reviewed |
 | Berger, M.* , Toussaint, F.* , Djemaa, S. B.* , Maquoi, E., Pendeville-Samain, H., Evrard, B., Jérôme, C., Chain, J. L., Lechanteur, A., Mottet, D.* , Debuigne, A.* , & Piel, G.*. (2024). Poly(N-methyl‐N‐vinylacetamide): a strong alternative to PEG for lipid‐based nanocarriers delivering siRNA. Advanced Healthcare Materials, 2302712. doi:10.1002/adhm.202302712 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
  | Berger, M. (2023). Development of lipid nanoparticles based on PEG alternatives for efficient siRNA delivery [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/307614 |
 | Berger, M.* , Toussaint, F.* , Djemaa, S. B.* , Laloy, J., Pendeville-Samain, H., Evrard, B., Jérôme, C., Lechanteur, A., Mottet, D.* , Debuigne, A.* , & Piel, G.*. (02 August 2023). Poly(vinyl pyrrolidone) derivatives as PEG alternatives for stealth, non-toxic and less immunogenic siRNA-containing lipoplex delivery. Journal of Controlled Release, 361, 87 - 101. doi:10.1016/j.jconrel.2023.07.031 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (27 April 2023). Effect of PEG anchor and serum on Lipid Nanoparticles: development of a nanoparticle tracking method [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium. |
Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (21 March 2023). Impact of the hydrophobic chain length of PEG derivatives on the behavior of LNPs in serum: Development of a Nanoparticle Tracking Analysis (NTA) Method [Poster presentation]. 4th European Conference on Pharmaceutics, Marseille, France. Peer reviewed |
 | Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (10 February 2023). Effect of PEG Anchor and Serum on Lipid Nanoparticles: Development of a Nanoparticles Tracking Method. Pharmaceutics, 15 (2). doi:10.3390/pharmaceutics15020597 Peer Reviewed verified by ORBi |
Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (01 February 2023). Effect of PEG anchor and serum on Lipid Nanoparticles: development of a nanoparticles tracking method [Paper presentation]. CIRM Day, Liege, Belgium. |
Debuigne, A., Piel, G., Mottet, D., Toussaint, F., Berger, M., Ben Djemaa, S., & Lechanteur, A. (2023). Polymer Derivative and their use as lipid nanoparticle modifiers”. |
Toussaint, F., Berger, M., Lechanteur, A., Jérôme, C., Piel, G., & Debuigne, A. (15 November 2022). Amphiphilic poly(N-vinylpyrrolidone)-based lipoplex modifiers for drug delivery applications [Paper presentation]. Belgian Polymer Group (BPG) Annual Meeting, Blankenberge, Belgium. |
Toussaint, F., Berger, M., Lechanteur, A., Jérôme, C., Piel, G., & Debuigne, A. (14 June 2022). Novel polyvinylpyrrolidone-based lipoplex modifiers for siRNA delivery [Poster presentation]. Bordeaux Polymer Conference, Bordeaux, France. |
Toussaint, F., Berger, M., Lechanteur, A., Jérôme, C., Piel, G., & Debuigne, A. (01 June 2022). PNVP as PEG alternative for lipoplex modification in siRNA delivery application [Poster presentation]. Advanced Functional Polymers for Medecine (AFPM), Nice, France. |
Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (30 March 2022). Development of innovative grafted lipoplexes using PNVP-derivatives polymers as a PEG alternative to treat cancer [Paper presentation]. 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP World Meeting), Rotterdam, Netherlands. |
Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (09 March 2022). Development of innovative grafted lipoplexes using PNVP-derivatives polymers as a PEG alternative to treat cancer [Paper presentation]. 2022 Meeting of the Germany and BeNeLux & France Local Chapters of the Controlled Release Society in Aachen, Aachen, Germany. |
Berger, M., Toussaint, F., Evrard, B., Jérôme, C., Lechanteur, A., Debuigne, A., & Piel, G. (02 February 2022). PNVP-polymers as a promising polyethyleneglycol (PEG) alternative onto anti-tumor lipoplexes surface [Paper presentation]. CIRM-Day, Liege, Belgium. |
 | Berger, M., Lechanteur, A., Evrard, B., & Piel, G. (2021). Innovative lipoplexes formulations with enhanced siRNA efficacy for cancer treatment: Where are we now? International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2021.120851 Peer Reviewed verified by ORBi |
Toussaint, F., Berger, M., Sanaa, B. D., Lechanteur, A., Jérôme, C., Piel, G., Mottet, D., & Debuigne, A. (27 May 2021). Polyvinylpyrrolidone compounds as PEG alternatives for lipoplex modification [Poster presentation]. Belgian Polymer Group (BPG) Annual Meeting, remote, Belgium. |
Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Debuigne, A., Mottet, D., Lechanteur, A., & Piel, G. (May 2021). Impact of amphiphilic N-vinyl pyrrolidone-based polymers used as PEG alternative on lipoplexes physico-chemical properties, cytotoxicity and gene delivery [Poster presentation]. Center for Interdisciplinary Research on Medicines (CIRM) Scientific Day, Liège, Belgium. |
Berger, M., Toussaint, F., Pairoux, C., Evrard, B., Jérôme, C., Lechanteur, A., Debuigne, A., & Piel, G. (06 April 2021). Amphiphilic N-vinyl pyrrolidone-based polymers as PEG alternatives to avoid blood proteins adsorption around liposomes [Paper presentation]. Early Career Scientist Meeting 2021. |
Berger, M., Toussaint, F., Pairoux, C., Evrard, B., Jérôme, C., Lechanteur, A., Debuigne, A., & Piel, G. (04 March 2021). Impact of amphiphilic copolymer used as PEG alternative on the formation of a protein corona around coated-liposomes encapsulating siRNA [Paper presentation]. 2021 - Virtual Local Chapter Meeting Germany and BeNeLux & France, Aachen, Germany. |
